Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5-lipoxygenase. It has antineoplastic activities.
Molecular Weight:
544.6
Purity:
98.92%
CAS Number:
[161172-51-6]
Formula:
C33H33FO6
Target:
Apoptosis|||Leukotriene Receptor|||LTR
T22358
* VAT and and shipping costs not included. Errors and price changes excepted